Durvalumab/olaparib interactionRemitting seronegative symmetric synovitis with pitting oedema: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1761卷 / 1期

关键词：

D O I：

10.1007/s40278-019-64527-5

中图分类号：

学科分类号：

摘要：

引用

页码：155 / 155

共 50 条

[1] NivolumabRemitting seronegative symmetrical synovitis with pitting oedema: case report
Reactions Weekly, 2017, 1679 (1) : 142 - 142
[2] TozinameranRemitting seronegative symmetrical synovitis with pitting oedema: case report
Reactions Weekly, 2021, 1881 (1) : 246 - 246
[3] SitagliptinRemitting seronegative symmetrical synovitis with pitting oedema: case report
Reactions Weekly, 2021, 1868 (1) : 374 - 374
[4] NivolumabRemitting seronegative symmetrical synovitis with pitting oedema: case report
Reactions Weekly, 2018, 1696 (1) : 283 - 283
[5] NivolumabRemitting seronegative symmetrical synovitis with pitting oedema syndrome: case report
Reactions Weekly, 2017, 1671 (1) : 311 - 311
[6] PembrolizumabRemitting seronegative symmetrical synovitis with pitting oedema syndrome: case report
Reactions Weekly, 2023, 1945 (1) : 439 - 439
[7] PembrolizumabRemitting seronegative symmetrical synovitis with pitting oedema syndrome : case report
Reactions Weekly, 2024, 2020 (1) : 382 - 382
[8] Remitting Seronegative Symmetrical Synovitis With Pitting Oedema Associated With Malignancy: A Case Report
Matos, Maria Ines
Rocha, Joao
Matos, Mariana
Brito, Maria Teresa
Ferreira, Susana
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
[9] InsulinsRemitting seronegative symmetrical synovitis with pitting oedema in an elderly patient: case report
Reactions Weekly, 2014, 1496 (1) : 26 - 26
[10] PembrolizumabParaneoplastic remitting seronegative symmetrical synovitis with pitting oedema syndrome: case report
Reactions Weekly, 2020, 1801 (1) : 217 - 217

← 1 2 3 4 5 →